Novel prediction methods for virtual drug screening

TL;DR

This paper discusses the development and application of machine learning, especially deep learning, in virtual drug screening to improve efficiency and accuracy in early drug discovery, highlighting recent advances and ongoing challenges.

Contribution

It reviews recent deep learning approaches for virtual drug screening, emphasizing their potential and the challenges faced in integrating these methods into drug discovery.

Findings

Deep learning models reduce computational costs compared to traditional methods.

Neural networks enable the generation of novel chemical structures.

Challenges include data quality and model interpretability.

Abstract

Drug development is an expensive and time-consuming process where thousands of chemical compounds are being tested in order to find those possessing drug-like properties while being safe and effective. One of key parts of the early drug discovery process has become virtual drug screening -- a method used to narrow down search for potential drugs by running computer simulations of drug-target interactions. As these methods are known to demand huge amounts of computational power to get accurate results, prediction models based on machine learning techniques became a popular solution requiring less computational power as well as offering the ability to generate novel chemical structures for further research. Deep learning is to stay in drug discovery but has a long way to go. Only in the past few years with increases in computing power have researchers really started to embrace the potential of neural networks in various stages of the drug discovery process. While prediction methods promise great perspective in the future development of drug discovery they open new questions and challenges that still have to be solved.